Public Joint Stock Company Polyus
Public Joint Stock Company Polyus Fundamental Analysis
Public Joint Stock Company Polyus (OPYGY) shows moderate financial fundamentals with a PE ratio of 8.31, profit margin of 44.66%, and ROE of 1.83%. The company generates $12.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 64.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze OPYGY's fundamental strength across five key dimensions:
Efficiency Score
ExcellentOPYGY demonstrates superior asset utilization.
Valuation Score
ExcellentOPYGY trades at attractive valuation levels.
Growth Score
ModerateOPYGY shows steady but slowing expansion.
Financial Health Score
ModerateOPYGY shows balanced financial health with some risks.
Profitability Score
ExcellentOPYGY achieves industry-leading margins.
Key Financial Metrics
Is OPYGY Expensive or Cheap?
P/E Ratio
OPYGY trades at 8.31 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, OPYGY's PEG of -10.74 indicates potential undervaluation.
Price to Book
The market values Public Joint Stock Company Polyus at 10.57 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 6.33 times EBITDA. This is generally considered low.
How Well Does OPYGY Make Money?
Net Profit Margin
For every $100 in sales, Public Joint Stock Company Polyus keeps $44.66 as profit after all expenses.
Operating Margin
Core operations generate 62.41 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.83 in profit for every $100 of shareholder equity.
ROA
Public Joint Stock Company Polyus generates $25.37 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Public Joint Stock Company Polyus generates strong operating cash flow of $6.88B, reflecting robust business health.
Free Cash Flow
Public Joint Stock Company Polyus generates strong free cash flow of $5.61B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $4.14 in free cash annually.
FCF Yield
OPYGY converts 8.89% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
8.31
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-10.74
vs 25 benchmark
P/B Ratio
Price to book value ratio
10.57
vs 25 benchmark
P/S Ratio
Price to sales ratio
5.25
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
3.35
vs 25 benchmark
Current Ratio
Current assets to current liabilities
5.53
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
1.83
vs 25 benchmark
ROA
Return on assets percentage
0.25
vs 25 benchmark
ROCE
Return on capital employed
0.38
vs 25 benchmark
How OPYGY Stacks Against Its Sector Peers
| Metric | OPYGY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 8.31 | 27.01 | Better (Cheaper) |
| ROE | 182.79% | 949.00% | Weak |
| Net Margin | 44.66% | -16159.00% (disorted) | Strong |
| Debt/Equity | 3.35 | 0.48 | Weak (High Leverage) |
| Current Ratio | 5.53 | 4.42 | Strong Liquidity |
| ROA | 25.37% | -6411.00% (disorted) | Strong |
OPYGY outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Public Joint Stock Company Polyus's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Commodity, Value
EPS CAGR
N/A
Industry Style: Cyclical, Commodity, Value
FCF CAGR
N/A
Industry Style: Cyclical, Commodity, Value